| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | 0.49 | 7e-49 |
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | 0.48 | 1e-47 |
| mRNA | XL-184 | GDSC1000 | pan-cancer | AAC | 0.31 | 1e-20 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | 0.44 | 6e-18 |
| mRNA | Sunitinib | GDSC1000 | pan-cancer | AAC | 0.39 | 2e-16 |
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | 0.23 | 2e-12 |
| mRNA | Midostaurin | GDSC1000 | pan-cancer | AAC | 0.23 | 1e-11 |
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | 0.22 | 7e-11 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | 0.23 | 4e-10 |
| mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | 0.21 | 7e-10 |